{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:40:42Z","timestamp":1791582042451,"version":"4.3.4"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560419"],"award-info":[{"award-number":["81560419"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20151BAB205047"],"award-info":[{"award-number":["20151BAB205047"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00504","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T05:08:22Z","timestamp":1588223302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":45,"title":["Pharmacological Interventions for Bacterial Prostatitis"],"prefix":"10.3389","volume":"11","author":[{"given":"Situ","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechao","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/iju.13451","article-title":"Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era","volume":"25","author":"Ackerman","year":"2018","journal-title":"Int. J. Urol."},{"key":"B2","first-page":"52","article-title":"Wardenafil in combined treatment of patients with chronic bacterial prostatitis","volume":"6","author":"Aliaev","year":"2008","journal-title":"Urologiia."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/j.idcr.2019.e00493","article-title":"Chronic prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli managed using oral fosfomycin-A case report","volume":"15","author":"Almeida","year":"2019","journal-title":"IDCases"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1128\/AEM.69.8.4474-4481.2003","article-title":"Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli","volume":"69","author":"Andrea","year":"2003","journal-title":"Appl. Environ. Microbiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1089\/end.2008.0265","article-title":"Ultrasound-guided transrectal placement of a drainage tube as therapeutic management of patients with prostatic abscess","volume":"22","author":"Aravantinos","year":"2008","journal-title":"J. Endourol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00345-013-1145-9","article-title":"The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: Results from a longitudinal cohort study","volume":"32","author":"Bartoletti","year":"2014","journal-title":"World J. Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ucl.2007.09.008","article-title":"Bacterial prostatitis","volume":"35","author":"Benway","year":"2008","journal-title":"Urol. Clin. North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1128\/iai.70.1.204-210.2002","article-title":"Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium","volume":"70","author":"Biswas","year":"2002","journal-title":"Infect. Immun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ijid.2008.01.006","article-title":"Is phage therapy acceptable in the immunocompromised host","volume":"12","author":"Borysowski","year":"2008","journal-title":"Int. J. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/1751-7915.12113","article-title":"Coverage of diarrhoea-associated Escherichia coli isolates from different origins with two types of phage cocktails","volume":"7","author":"Bourdin","year":"2014","journal-title":"Microb. Biotechnol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrurol.2011.22","article-title":"The etiology and management of acute prostatitis","volume":"8","author":"Brede","year":"2011","journal-title":"Nat. Rev. Urol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s0090-4295(03)00565-x","article-title":"Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: A randomized double-blind multicenter study","volume":"62","author":"Bundrick","year":"2003","journal-title":"Urology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ijantimicag.2008.11.012","article-title":"Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: Results from a prospective randomised study","volume":"33","author":"Cai","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12275-011-0391-z","article-title":"Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis","volume":"49","author":"Cai","year":"2011","journal-title":"J. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1111\/jsm.12699","article-title":"Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study","volume":"11","author":"Cai","year":"2014","journal-title":"J. Sex Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4081\/aiua.2016.3.177","article-title":"Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients","volume":"88","author":"Cai","year":"2016","journal-title":"Arch. Ital Urol. Androl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.4111\/icu.2018.59.3.187","article-title":"Prostate calcifications: A case series supporting the microbial biofilm theory","volume":"59","author":"Cai","year":"2018","journal-title":"Invest. Clin. Urol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2005.03.008","article-title":"EAU guidelines for the management of genitourinary tuberculosis","volume":"48","author":"Cek","year":"2005","journal-title":"Eur. Urol."},{"key":"B20","unstructured":"Antibiotic resistance threats in the United States, 2013.2013"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502765","article-title":"The use of a combination of vaccinium macracarpon, lycium barbarum l. And probiotics (Bifiprost\u00ae) for the prevention of chronic bacterial prostatitis: A Double-Blind randomized study","volume":"4","author":"Chiancone","year":"2019","journal-title":"Urol. Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1128\/AAC.48.7.2558-2569.2004","article-title":"In vitro and in vivo bacteriolytic activities of Escherichia coli phages: Implications for phage therapy","volume":"48","author":"Chibani-Chennoufi","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ultrasmedbio.2004.03.014","article-title":"Prostatic abscess: Transrectal color Doppler ultrasonic diagnosis and minimally invasive therapeutic management","volume":"30","author":"Chou","year":"2004","journal-title":"Ultrasound Med. Biol."},{"key":"B24","first-page":"114","article-title":"Acute bacterial prostatitis: Diagnosis and management","volume":"93","author":"Coker","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","article-title":"How common is prostatitis? A national survey of physician visits","volume":"159","author":"Collins","year":"1998","journal-title":"J. Urol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","article-title":"Phage-Antibiotic Synergy (PAS): Beta-lactam and quinolone antibiotics stimulate virulent phage growth","volume":"2","author":"Comeau","year":"2007","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1128\/AAC.01718-12","article-title":"Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-beta-lactamase-producing Escherichia coli in a foreign-body infection model","volume":"57","author":"Corvec","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"Bmj"},{"key":"B29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1146\/annurev.mi.49.100195.003431","article-title":"Microbial biofilms","volume":"49","author":"Costerton","year":"1995","journal-title":"Annu. Rev. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ijantimicag.2014.12.019","article-title":"Persistent extended-spectrum beta-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline","volume":"45","author":"Cunha","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0090-4295(93)90584-w","article-title":"Diagnosis and treatment of 409 patients with prostatitis syndromes","volume":"41","author":"de la Rosette","year":"1993","journal-title":"Urology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"i57","DOI":"10.1093\/jac\/dkt027","article-title":"Molecular epidemiology of extended-spectrum beta-lactamase-, AmpC beta-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11","author":"Denisuik","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tim.2008.11.002","article-title":"Preventing biofilms of clinically relevant organisms using bacteriophage","volume":"17","author":"Donlan","year":"2009","journal-title":"Trends Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1139\/m95-002","article-title":"Lytic infection of Escherichia coli biofilms by bacteriophage T4","volume":"41","author":"Doolittle","year":"1995","journal-title":"Can. J. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2334-8-12","article-title":"Acute bacterial prostatitis: Heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis","volume":"8","author":"Etienne","year":"2008","journal-title":"BMC Infect. Dis."},{"key":"B37","first-page":"247","article-title":"Antibacterial substances in prostatic fluid","author":"Fair","year":"1981","journal-title":"Prog. Clin. Biol. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/cid\/civ443","article-title":"Editorial commentary: Fosfomycin: The current status of the drug","volume":"61","author":"Falagas","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/and.13021","article-title":"Pharmacodynamic and pharmacokinetic studies and prostatic tissue distribution of fosfomycin tromethamine in bacterial prostatitis or normal rats","volume":"50","author":"Fan","year":"2018","journal-title":"Andrologia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3906\/yer-1412-34","article-title":"Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets","volume":"28","author":"Fayyaz","year":"2015","journal-title":"Pak J. Pharm. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jac\/dkn337","article-title":"Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates","volume":"62","author":"Garcia-Castillo","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1093\/cid\/cit704","article-title":"Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis","volume":"58","author":"Gardiner","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/QCO.0000000000000222","article-title":"Bacterial prostatitis","volume":"29","author":"Gill","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1117\/12.895292","article-title":"Bacteriophage therapy for the treatment of infections","volume":"10","author":"Gorski","year":"2009","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"B45","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2217\/fmb.14.126","article-title":"Phages targeting infected tissues: Novel approach to phage therapy","volume":"10","author":"Gorski","year":"2015","journal-title":"Future Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1442-2042.1998.tb00597.x","article-title":"Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate","volume":"5","author":"Goto","year":"1998","journal-title":"Int. J. Urol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/109505","article-title":"Transurethral resection of prostate abscess: Is it different from conventional transurethral resection for benign prostatic hyperplasia","volume":"2013","author":"Goyal","year":"2013","journal-title":"ISRN Urol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2165\/00003495-200969070-00002","article-title":"Cranberry and urinary tract infections","volume":"69","author":"Guay","year":"2009","journal-title":"Drugs"},{"key":"B49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1139\/w99-065","article-title":"The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber","volume":"45","author":"Habash","year":"1999","journal-title":"Can. J. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/jac\/48.1.53","article-title":"Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems","volume":"48","author":"Hallgren","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/j.ijantimicag.2007.07.016","article-title":"Synergistic effect between lycopene and ciprofloxacin on a chronic bacterial prostatitis rat model","volume":"31","author":"Han","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijantimicag.2007.04.006","article-title":"Bacteriophages: An appraisal of their role in the treatment of bacterial infections","volume":"30","author":"Hanlon","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.mib.2008.09.004","article-title":"Bacteriophage genomics","volume":"11","author":"Hatfull","year":"2008","journal-title":"Curr. Opin. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.medcli.2016.05.018","article-title":"Chronic bacterial prostatitis. Clinical and microbiological study of 332 cases","volume":"147","author":"Heras-Canas","year":"2016","journal-title":"Med. Clin. (Barc)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.diagmicrobio.2012.05.024","article-title":"Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: Results from the SMART study 2009-2010","volume":"74","author":"Hoban","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJM199810083391516","article-title":"Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries","volume":"339","author":"Howell","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B57","first-page":"580","article-title":"Treatment of chronic bacterial prostatitis by perfusion with double-balloon and triple-channel catheter: A control study","volume":"9","author":"Huang","year":"2003","journal-title":"Zhonghua Nan Ke Xue"},{"key":"B58","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1099\/00221287-144-11-3039","article-title":"Biofilm susceptibility to bacteriophage attack: The role of phage-borne polysaccharide depolymerase","volume":"144","author":"Hughes","year":"1998","journal-title":"Microbiology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijantimicag.2014.06.011","article-title":"Enhanced penetration of moxifloxacin into rat prostate tissue evidenced by microdialysis","volume":"44","author":"Hurtado","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0065-2164(10)70007-1","article-title":"Bacteriophage host range and bacterial resistance","volume":"70","author":"Hyman","year":"2010","journal-title":"Adv. Appl. Microbiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1745-7262.2008.00344.x","article-title":"Distribution of secretory inhibitor of platelet microbicidal protein among urethral isolates with its correlation with prostatitis","volume":"10","author":"Ivanov","year":"2008","journal-title":"Asian J. Androl."},{"key":"B62","first-page":"34","article-title":"Clinical immunological rationale of interferon therapy in chronic bacterial prostatitis","volume":"1","author":"Kamalov","year":"2010","journal-title":"Urologiia"},{"key":"B63","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ijantimicag.2006.05.006","article-title":"Increased biofilm formation in Escherichia coli isolated from acute prostatitis","volume":"28","author":"Kanamaru","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B64","first-page":"1621","article-title":"Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: A randomized controlled trial","volume":"92","author":"Kanjanawongdeengam","year":"2009","journal-title":"J. Med. Assoc. Thai"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1093\/jac\/dkz015","article-title":"Oral fosfomycin for the treatment of chronic bacterial prostatitis","volume":"74","author":"Karaiskos","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1128\/AAC.00066-11","article-title":"Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study","volume":"55","author":"Karlowsky","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/AAC.02399-13","article-title":"In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study","volume":"58","author":"Karlowsky","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.biopha.2017.08.016","article-title":"Comprehensive overview of prostatitis","volume":"94","author":"Khan","year":"2017","journal-title":"BioMed. Pharmacother."},{"key":"B69","first-page":"91","article-title":"Combination therapy of chronic bacterial prostatitis","volume":"3","author":"Khryanin","year":"2016","journal-title":"Urologiia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10156-010-0170-5","article-title":"Do Escherichia coli extract and cranberry exert preventive effects on chronic bacterial prostatitis? Pilot study using an animal model","volume":"17","author":"Kim","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10156-011-0276-4","article-title":"Preventive effect of selenium on chronic bacterial prostatitis","volume":"18","author":"Kim","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10156-012-0406-7","article-title":"Preventive effect of ginsenoid on chronic bacterial prostatitis","volume":"18","author":"Kim","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jiac.2013.11.004","article-title":"Microbiological and clinical characteristics in acute bacterial prostatitis according to lower urinary tract manipulation procedure","volume":"20","author":"Kim","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.17116\/kurort2015540-44","article-title":"The application of the combined resonance-wave therapy for the treatment of the patients presenting with chronic bacterial prostatitis","volume":"92","author":"Kiyatkin","year":"2015","journal-title":"Vopr Kurortol. Fizioter Lech Fiz Kult"},{"key":"B75","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.1021\/jf801345c","article-title":"Anthocyanins from black soybean seed coats inhibit UVB-induced inflammatory cylooxygenase-2 gene expression and PGE2 production through regulation of the nuclear factor-kappaB and phosphatidylinositol 3-kinase\/Akt pathway","volume":"56","author":"Konstantin","year":"2008","journal-title":"J. Agric. Food Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0090-4295(91)80004-q","article-title":"Comprehensive evaluation and treatment of 75 men referred to chronic prostatitis clinic","volume":"38","author":"Krieger","year":"1991","journal-title":"Urology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.282.3.236","article-title":"NIH consensus definition and classification of prostatitis","volume":"282","author":"Krieger","year":"1999","journal-title":"Jama"},{"key":"B78","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0302-2838(02)00270-1","article-title":"Cost effectiveness model comparing trimethoprim sulfamethoxazole and ciprofloxacin for the treatment of chronic bacterial prostatitis","volume":"42","author":"Kurzer","year":"2002","journal-title":"Eur. Urol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrmicro2315","article-title":"Bacteriophage resistance mechanisms","volume":"8","author":"Labrie","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(16)31079-0","article-title":"UN High-Level Meeting on antimicrobials\u2013what do we need","volume":"388","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1442-2042.2005.01052.x","article-title":"Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model","volume":"12","author":"Lee","year":"2005","journal-title":"Int. J. Urol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000320109","article-title":"Does finasteride have a preventive effect on chronic bacterial prostatitis? Pilot study using an animal model","volume":"86","author":"Lee","year":"2011","journal-title":"Urol. Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12223-009-0064-z","article-title":"Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis\u2013case report","volume":"54","author":"Letkiewicz","year":"2009","journal-title":"Folia Microbiol. (Praha)"},{"key":"B84","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1569-9056(10)60372-7","article-title":"Pathogen eradication by phage therapy in patients with chronic bacterial prostatitis","volume":"9","author":"Letkiewicz","year":"2010","journal-title":"Eur. Urol. Suppl."},{"key":"B85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1574-695X.2010.00723.x","article-title":"The perspectives of the application of phage therapy in chronic bacterial prostatitis","volume":"60","author":"Letkiewicz","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrmicro822","article-title":"Population and evolutionary dynamics of phage therapy","volume":"2","author":"Levin","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12013-012-9383-9","article-title":"Mechanisms of prostate permeability triggered by microbubble-mediated acoustic cavitation","volume":"64","author":"Li","year":"2012","journal-title":"Cell Biochem. Biophysics"},{"key":"B88","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest Pharmacol. Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1086\/652861","article-title":"Treatment of bacterial prostatitis","volume":"50","author":"Lipsky","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.urology.2012.12.022","article-title":"Effect of microbubble-enhanced ultrasound on prostate permeability: A potential therapeutic method for prostate disease","volume":"81","author":"Liu","year":"2013","journal-title":"Urology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1467-842X.2006.tb00794.x","article-title":"Increased oxidative stress and damage in patients with chronic bacterial prostatitis","volume":"19","author":"Lou","year":"2006","journal-title":"BioMed. Environ. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"11197","DOI":"10.1073\/pnas.0704624104","article-title":"Dispersing biofilms with engineered enzymatic bacteriophage","volume":"104","author":"Lu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B93","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1439-0272.2007.00823.x","article-title":"Diagnosis and therapy of acute prostatitis, epididymitis and orchitis","volume":"40","author":"Ludwig","year":"2008","journal-title":"Andrologia"},{"key":"B94","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"B95","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/aja.2009.5","article-title":"Semen analysis in chronic bacterial prostatitis: Diagnostic and therapeutic implications","volume":"11","author":"Magri","year":"2009","journal-title":"Asian J. Androl."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/cid\/cir709","article-title":"Chronic bacterial prostatitis: Enterococcal disease","volume":"53","author":"Magri","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/aja.2011.36","article-title":"Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: Retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction","volume":"13","author":"Magri","year":"2011","journal-title":"Asian J. Androl."},{"key":"B98","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000499034","article-title":"Levofloxacin for NIH category II chronic bacterial prostatitis: A Real-Life study","volume":"64","author":"Magri","year":"2019","journal-title":"Chemotherapy"},{"key":"B99","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1574-695X.2010.00659.x","article-title":"Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications","volume":"59","author":"Mazzoli","year":"2010","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.virol.2013.05.022","article-title":"Safety analysis of a Russian phage cocktail: From metagenomic analysis to oral application in healthy human subjects","volume":"443","author":"McCallin","year":"2013","journal-title":"Virology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.virusres.2007.09.013","article-title":"Bacteriophage preparation inhibition of reactive oxygen species generation by endotoxin-stimulated polymorphonuclear leukocytes","volume":"131","author":"Miedzybrodzki","year":"2008","journal-title":"Virus Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10238-009-0044-2","article-title":"A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses","volume":"9","author":"Miedzybrodzki","year":"2009","journal-title":"Clin. Exp. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00345-005-0040-4","article-title":"Acute bacterial prostatitis: Two different sub-categories according to a previous manipulation of the lower urinary tract","volume":"24","author":"Millan-Rodriguez","year":"2006","journal-title":"World J. Urol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1442-2042.2007.01975.x","article-title":"Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: Report of four cases and review of the literature","volume":"15","author":"Miura","year":"2008","journal-title":"Int. J. Urol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","article-title":"Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases","volume":"13","author":"Munoz-Price","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1439-0272.2003.tb00868.x","article-title":"Antibiotic therapy\u2013rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue","volume":"35","author":"Naber","year":"2003","journal-title":"Andrologia"},{"key":"B108","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/bf01710740","article-title":"Penetration of ofloxacin into prostatic fluid, ejaculate and seminal fluid","volume":"21","author":"Naber","year":"1993","journal-title":"Infection"},{"key":"B109","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1128\/AAC.45.1.293-297.2001","article-title":"Concentrations of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate, and sperm cells after single oral administrations of 400 milligrams to volunteers","volume":"45","author":"Naber","year":"2001","journal-title":"Antimicrobial Agents Chemother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijantimicag.2008.03.014","article-title":"Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis","volume":"32","author":"Naber","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B111","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000342653","article-title":"Acute bacterial prostatitis in humans: Current microbiological spectrum, sensitivity to antibiotics and clinical findings","volume":"89","author":"Nagy","year":"2012","journal-title":"Urol. Int."},{"key":"B112","first-page":"73","article-title":"Characteristic of gram-positive microorganisms isolated during chronic bacterial prostatitis","volume":"5","author":"Neimark","year":"2010","journal-title":"Zh Mikrobiol. Epidemiol. Immunobiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"e01874","DOI":"10.1128\/mBio","article-title":"Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers","volume":"8","author":"Nguyen","year":"2017","journal-title":"MBio"},{"key":"B114","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3909\/riu0557","article-title":"Alpha-Blockers for the treatment of chronic Prostatitis\/Chronic pelvic pain syndrome: An update on current clinical evidence","volume":"14","author":"Nickel","year":"2012","journal-title":"Rev. Urol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.juro.2007.11.081","article-title":"Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis","volume":"179","author":"Nickel","year":"2008","journal-title":"J. Urol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1007\/bf01643681","article-title":"Rat model of experimental bacterial prostatitis","volume":"19","author":"Nickel","year":"1991","journal-title":"Infection"},{"key":"B117","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/00005392-199502000-00076","article-title":"Antibiotic pharmacokinetics in the inflamed prostate","volume":"153","author":"Nickel","year":"1995","journal-title":"J. Urol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0022-5347(06)00498-8","article-title":"How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis\/chronic pelvic pain syndrome","volume":"176","author":"Nickel","year":"2006","journal-title":"J. Urol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00705-007-0031-4","article-title":"T-even-related bacteriophages as candidates for treatment of Escherichia coli urinary tract infections","volume":"153","author":"Nishikawa","year":"2008","journal-title":"Arch. Virol."},{"key":"B120","first-page":"46","article-title":"Immunocorrecting therapy of chronic bacterial prostatitis","volume":"44","author":"Novikov","year":"2010","journal-title":"Urologiia"},{"key":"B121","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: A clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1056\/NEJMra0904124","article-title":"Hospital-acquired infections due to gram-negative bacteria","volume":"362","author":"Peleg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/mmr.2011.575","article-title":"Macrolides for the treatment of chronic bacterial prostatitis: An effective application of their unique pharmacokinetic and pharmacodynamic profile (Review)","volume":"4","author":"Perletti","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"D9071","DOI":"10.1002\/14651858.CD009071.pub2","article-title":"Antimicrobial therapy for chronic bacterial prostatitis","volume":"8","author":"Perletti","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-like carbapenemases: The phantom menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B126","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0090-4295(02)02381-6","article-title":"Inflammation and anti-inflammatory therapy in chronic prostatitis","volume":"60","author":"Pontari","year":"2002","journal-title":"Urology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.juro.2007.01.128","article-title":"Prostatitis","volume":"177","author":"Pontari","year":"2007","journal-title":"J. Urol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijantimicag.2006.08.039","article-title":"Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections","volume":"29","author":"Pullukcu","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B129","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.pop.2010.04.007","article-title":"Prostatitis: Acute and chronic","volume":"37","author":"Ramakrishnan","year":"2010","journal-title":"Primary Care"},{"key":"B130","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/bju.13101","article-title":"Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis\/chronic pelvic pain syndrome: A consensus guideline","volume":"116","author":"Rees","year":"2015","journal-title":"BJU Int."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/jac\/dkv067","article-title":"Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis","volume":"70","author":"Rhodes","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B132","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/s0090-4295(98)00034-x","article-title":"Prevalence of a physician-assigned diagnosis of prostatitis: The Olmsted County Study of Urinary Symptoms and Health Status Among Men","volume":"51","author":"Roberts","year":"1998","journal-title":"Urology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1128\/AAC.02052-13","article-title":"Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries","volume":"58","author":"Rogers","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B134","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jiac.2016.01.010","article-title":"Fosfomycin: Resurgence of an old companion","volume":"22","author":"Sastry","year":"2016","journal-title":"J. Infect. Chemother."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1056\/NEJMcp060423","article-title":"Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome","volume":"355","author":"Schaeffer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s00345-017-2054-0","article-title":"Surgical therapy of prostatitis: A systematic review","volume":"35","author":"Schoeb","year":"2017","journal-title":"World J. Urol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1179\/joc.2010.22.5.355","article-title":"Carbapenem versus fosfomycin tromethanol in the treatment of Extended-Spectrum Beta-Lactamase-Producing escherichia Coli-Related complicated lower urinary tract infection","volume":"22","author":"Senol","year":"2010","journal-title":"J. Chemother."},{"key":"B138","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1442-2042.2003.00666.x","article-title":"Effects of androgen deprivation on chronic bacterial prostatitis in a rat model","volume":"10","author":"Seo","year":"2003","journal-title":"Int. J. Urol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/srep07233","article-title":"The effect of chronic bacterial prostatitis on semen quality in adult men: A meta-analysis of case-control studies","volume":"4","author":"Shang","year":"2014","journal-title":"Sci. Rep."},{"key":"B140","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/bmj.c3929","article-title":"Prostatitis: Diagnosis and treatment","volume":"82","author":"Sharp","year":"2010","journal-title":"Am. Fam. Physician"},{"key":"B141","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10156-007-0570-3","article-title":"Acute bacterial prostatitis after transrectal prostate needle biopsy: Clinical analysis","volume":"14","author":"Shigehara","year":"2008","journal-title":"J. Infect. Chemother."},{"key":"B142","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/s0090-4295(99)00358-1","article-title":"Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial","volume":"54","author":"Shoskes","year":"1999","journal-title":"Urology"},{"key":"B143","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00019048-200009090-00004","article-title":"Treatment of a complicated Vancomycin-Resistant enterococcal urinary tract infection with fosfomycin","volume":"9","author":"Shrestha","year":"2000","journal-title":"Infect. Dis. Clin. Pract."},{"key":"B144","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijantimicag.2004.03.014","article-title":"Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis","volume":"24","author":"Skerk","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B145","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijantimicag.2009.02.012","article-title":"Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model","volume":"34","author":"Sohn","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B146","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/1615-1003(200109)30:5<418::AID-PAUZ418>3.0.CO;2-","article-title":"How well do gyrase inhibitors work? The pharmacokinetics of quinolones","volume":"30","author":"Sorgel","year":"2001","journal-title":"Pharm. Unserer Zeit"},{"key":"B147","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.juro.2006.08.081","article-title":"Biofilm formation in uropathogenic Escherichia coli strains: Relationship with prostatitis, urovirulence factors and antimicrobial resistance","volume":"177","author":"Soto","year":"2007","journal-title":"J. Urol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4111\/icu.2017.58.4.271","article-title":"Mounting resistance of uropathogens to antimicrobial agents: A retrospective study in patients with chronic bacterial prostatitis relapse","volume":"58","author":"Stamatiou","year":"2017","journal-title":"Invest. Clin. Urol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S1166-7087(07)92397-0","article-title":"Epidemiology and treatment of acute prostatitis after prostatic biopsy","volume":"17","author":"Stoica","year":"2007","journal-title":"Prog. Urol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13099-016-0109-1","article-title":"Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model","volume":"8","author":"Tetz","year":"2016","journal-title":"Gut. Pathog."},{"key":"B151","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages","volume":"7","author":"Van Belleghem","year":"2017","journal-title":"Sci. Rep."},{"key":"B152","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15570\/actaapa.2015.8","article-title":"Diagnosis and treatment of bacterial prostatitis","volume":"24","author":"Videcnik","year":"2015","journal-title":"Acta Dermatovenerol. Alp Pannonica Adriat"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1017\/S0007114510002059","article-title":"The effectiveness of dried cranberries (Vaccinium macrocarpon) in men with lower urinary tract symptoms","volume":"104","author":"Vidlar","year":"2010","journal-title":"Br. J. Nutr."},{"key":"B155","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/0971-3026.120262","article-title":"Transrectal ultrasound-guided aspiration in the management of prostatic abscess: A single-center experience","volume":"23","author":"Vyas","year":"2013","journal-title":"Indian J. Radiol. Imaging"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2005.04.013","article-title":"The role of antibiotics in chronic bacterial prostatitis","volume":"26","author":"Wagenlehner","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B157","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1179\/joc.2006.18.5.485","article-title":"Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate","volume":"18","author":"Wagenlehner","year":"2006","journal-title":"J. Chemother."},{"key":"B158","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.ijantimicag.2007.07.029","article-title":"Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005","volume":"31","author":"Wagenlehner","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B159","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00345-013-1055-x","article-title":"Bacterial prostatitis","volume":"31","author":"Wagenlehner","year":"2013","journal-title":"World J. Urol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1586\/14787210.2014.856756","article-title":"The spread and acquisition of NDM-1: A multifactorial problem","volume":"12","author":"Wailan","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B161","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00003495-199958002-00021","article-title":"Outcome of antibiotic therapy with ciprofloxacin in chronic bacterial prostatitis","author":"Weidner","year":"1999","journal-title":"Drugs"},{"key":"B162","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.femsre.2003.08.001","article-title":"Ecology of prokaryotic viruses","volume":"28","author":"Weinbauer","year":"2004","journal-title":"FEMS Microbiol. Rev."},{"key":"B163","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11918-008-0014-2","article-title":"Atypical infections of the prostate","volume":"6","author":"Wise","year":"2008","journal-title":"Curr. Prostate Rep."},{"key":"B164","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1073\/pnas.93.18.9630","article-title":"In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: Relation to urinary tract infections","volume":"93","author":"Wu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. States America"},{"key":"B165","doi-asserted-by":"publisher","first-page":"e475","DOI":"10.1016\/j.juro.2013.02.802","article-title":"Novel algorithm for predicting severe cases of acute bacterial prostatitis","volume":"189","author":"Yazawa","year":"2013","journal-title":"J. Urol."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/srep19745","article-title":"Microbubble-mediated ultrasound promotes accumulation of bone marrow mesenchymal stem cell to the prostate for treating chronic bacterial prostatitis in rats","volume":"6","author":"Yi","year":"2016","journal-title":"Sci. Rep."},{"key":"B167","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10156-010-0098-9","article-title":"Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model","volume":"17","author":"Yoon","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"B168","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10156-011-0350-y","article-title":"Acute bacterial prostatitis: How to prevent and manage chronic infection","volume":"18","author":"Yoon","year":"2012","journal-title":"J. Infect. Chemother."},{"key":"B169","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11655-013-1547-y","article-title":"Anti-inflammatory and Antimicrobial Effects of Anthocyanin Extracted from Black Soybean on Chronic Bacterial Prostatitis Rat Model","volume":"24","author":"Yoon","year":"2018","journal-title":"Chin. J. Integr. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1073\/pnas.1500107112","article-title":"Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria","volume":"112","author":"Yosef","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"B171","doi-asserted-by":"publisher","first-page":"D7182","DOI":"10.1002\/14651858.CD007182.pub2","article-title":"Antimicrobial agents for treating uncomplicated urinary tract infection in women","volume":"10","author":"Zalmanovici","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"B172","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1590\/s1677-55382008000100006","article-title":"Semen and urine culture in the diagnosis of chronic bacterial prostatitis","author":"Zegarra","year":"2008","journal-title":"Int. Braz. J. Urol."},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2082693","article-title":"Fosfomycin: A First-Line oral therapy for acute uncomplicated cystitis","volume":"2016","author":"Zhanel","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1404813","article-title":"Oral fosfomycin for the treatment of acute and chronic bacterial prostatitis caused by Multidrug-Resistant escherichia coli","volume":"2018","author":"Zhanel","year":"2018","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/aja.2012.48","article-title":"Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients","volume":"14","author":"Zhang","year":"2012","journal-title":"Asian J. Androl."},{"key":"B176","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/aja.2012.40","article-title":"Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis","volume":"14","author":"Zhao","year":"2012","journal-title":"Asian J. Androl."},{"key":"B177","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1745-7262.2006.00144.x","article-title":"Increased oxidative stress and oxidative damage associated with chronic bacterial prostatitis","volume":"8","author":"Zhou","year":"2006","journal-title":"Asian J. Androl."},{"key":"B178","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2015.199","article-title":"The emerging threat of multidrug-resistant Gram-negative bacteria in urology","volume":"12","author":"Zowawi","year":"2015","journal-title":"Nat. Rev. Urol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00504\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T05:08:38Z","timestamp":1588223318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00504\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":178,"alternative-id":["10.3389\/fphar.2020.00504"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00504","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"article-number":"504"}}